ProMIS Neurosciences, Inc. (PMN)
9.035
+0.94
(+11.68%)
USD |
NASDAQ |
Oct 21, 16:00
9.035
0.00 (0.00%)
After-Hours: 18:51
ProMIS Neurosciences EPS Diluted (Quarterly) : -1.283 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.283 |
| March 31, 2026 | -1.263 |
| December 31, 2025 | -4.959 |
| September 30, 2025 | -5.928 |
| June 30, 2025 | -7.257 |
| March 31, 2025 | -0.2108 |
| December 31, 2024 | -0.1822 |
| September 30, 2024 | 0.3085 |
| June 30, 2024 | -0.1327 |
| March 31, 2024 | -0.1861 |
| December 31, 2023 | -0.1896 |
| September 30, 2023 | -0.1908 |
| June 30, 2023 | -0.2695 |
| March 31, 2023 | -0.5781 |
| December 31, 2022 | -0.908 |
| September 30, 2022 | -0.8279 |
| June 30, 2022 | -0.3815 |
| March 31, 2022 | -0.3377 |
| December 31, 2021 | -0.3227 |
| September 30, 2021 | -0.129 |
| June 30, 2021 | -0.0474 |
| March 31, 2021 | -1.224 |
| December 31, 2020 | -0.1091 |
| September 30, 2020 | -0.2431 |
| June 30, 2020 | -0.2512 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.2824 |
| December 31, 2019 | -0.24 |
| September 30, 2019 | -0.2849 |
| June 30, 2019 | -0.3242 |
| March 31, 2019 | -0.4346 |
| December 31, 2018 | -0.6411 |
| September 30, 2018 | -0.5426 |
| June 30, 2018 | -0.4647 |
| March 31, 2018 | -8.242 |
| December 31, 2017 | -0.472 |
| September 30, 2017 | -0.4787 |
| June 30, 2017 | -0.4462 |
| March 31, 2017 | -0.4534 |
| December 31, 2016 | -0.4497 |
| September 30, 2016 | -0.2259 |
| June 30, 2016 | -0.1969 |
| March 31, 2016 | -0.19 |
| December 31, 2015 | -0.2912 |
| September 30, 2015 | -0.4586 |
| June 30, 2015 | -0.1976 |
| March 31, 2015 | -0.4835 |
| December 31, 2014 | -0.5283 |
| September 30, 2014 | -0.5513 |
| June 30, 2014 | -0.5501 |
| March 31, 2014 | -0.5439 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Edesa Biotech, Inc. | -0.6003 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.73M |
| Total Expenses (Quarterly) | 11.73M |
| Enterprise Value | 19.09M |
| Earnings Yield | -148.7% |
| Normalized Earnings Yield | -148.70 |